Author: DelveInsight

Opioid Withdrawal Syndrome: What happens when a person withdraws from Opiates

Articles, Business Consultant, Pharma Consultant

The year 2016, around 48.5 million Americans older than 12 years, reported to be actively abusing prescription opioids or involved in...

Read More

Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust

Business Consultant, Pharma Consultant, Pharma news

Incyte meets endpoint in the second pivotal atopic dermatitis clinical trial A second phase 3 trial of Incyte’s ruxolitinib cream in...

Read More

Cardiovascular Disease: A major cause of health loss and a global burden

Business Consultant, Pharma Consultant, Snippets

Cardiovascular diseases (CVDs) are one of the leading causes of death and health loss in people in the US. As per a study by the National...

Read More

Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade

Articles, Business Consultant, Pharma Consultant

With no effective cure in Wet Age-related macular degeneration (Wet AMD) treatment market, the need of new therapies that can not only slow...

Read More

Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D

Articles, Business Consultant, Pharma Consultant

Nearly 11 million Americans are living with one or other type of Age-Related Macular degeneration (AMD), estimates BrightFocus foundation....

Read More
Close